Novozymes to merge with Danish bioscience group

The two companies announce plans to merge into a leading player globally, expectedly to ”unleash the full potential of biological solutions and generate significant value for all stakeholders and society at large”.
Photo: Martin Havtorn Petersen / Watch Medier
Photo: Martin Havtorn Petersen / Watch Medier
BY VIKTOR BRANDT KÆRGAARD & MARKETWIRE, TRANSLATED BY DANIEL FRANKCHRISTENSEN

Denmark’s Novozymes and compatriot bioscience firm Chr. Hansen are planning a merger to form a leading player within bioscience products globally, the companies inform in a press release.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    On June 1, Senvion's former CFO Manav Sharma started as US country manager for Nordex. Soon he will have a new factory at his disposal. | Foto: Senvion

    Nordex restarts production in the US

    For subscribers

    Further reading